Figure 3.

Event rates for gastroduodenal ulcers with nonsteroidal anti-inflammatory drug, coxib, or placebo, with low-dose aspirin. Pooled event rates for gastroduodenal ulcers detected endoscopically (predominantly 3 mm in largest diameter, with depth) at 6 or 12 weeks with NSAID, coxib, or placebo, according to use of low-dose aspirin.

Andrew Moore Arthritis Research & Therapy 2013 15(Suppl 3):S4   doi:10.1186/ar4176